Thyroid hormone beta receptor mutation causes renal dysfunction and impairment of ClC-2 chloride channel expression

Debora Dos Santos Ornellas1, Aline Cristina Gomes, Leticia Aragao Santiago

  • 1Laboratory of Molecular and Cellular Physiology, Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Abstract

Insights

Thyroid hormone resistance (RTH) in mice with a TR-beta mutation affects kidney function and ClC-2 chloride channel expression. Thyroid hormone modulates ClC-2 gene transcription through the TR-beta receptor pathway.

Area of Science:

  • Endocrinology
  • Nephrology
  • Molecular Biology

Background:

  • Resistance to thyroid hormone (RTH) is caused by mutations in the thyroid hormone receptor beta (TR-beta) gene.
  • The Delta337T mutation in TR-beta mimics RTH syndrome in mice, impacting renal function.

Purpose of the Study:

  • Investigate the role of the TR-beta receptor in thyroid hormone modulation of the ClC-2 channel in mouse kidneys.
  • Analyze the impact of RTH on renal electrolyte handling and ClC-2 expression.

Main Methods:

  • Studied renal RNA and protein expression of ClC-2 in normal and Delta337T mutant mice using RT-PCR and Western blot.
  • Assessed renal function via urinary electrolyte excretion analysis.
  • Examined ClC-2 promoter activity in immortalized renal proximal tubule cells in vitro.

Main Results:

  • RTH mice exhibited altered fractional excretion of sodium and chloride.
  • ClC-2 mRNA and protein expression were reduced by 40% in mutant mouse kidneys.
  • Thyroid hormone stimulated ClC-2 promoter activity in a dose-dependent manner in vitro.

Conclusions:

  • Thyroid hormone is crucial for electrolyte balance in the nephron.
  • The TR-beta receptor pathway mediates thyroid hormone's effect on renal ClC-2 gene transcription.

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...